BAM vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

BAM

31.5
AI Score
VS
IVZ Wins

IVZ

41.5
AI Score

Investment Advisor Scores

BAM

32score
Recommendation
SELL

IVZ

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BAM IVZ Winner
Forward P/E 28.2486 11.6686 IVZ
PEG Ratio 1.3479 0.9008 IVZ
Revenue Growth 60.8% 20.5% BAM
Earnings Growth 47.4% 35.0% BAM
Tradestie Score 31.5/100 41.5/100 IVZ
Profit Margin 48.9% -0.9% BAM
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD IVZ

Relative Price Performance (Last 90 Days)

BAM 1M: +14.4% · 3M: +7.7% IVZ 1M: +7.4% · 3M: +18.7%

Current Technical Phase

BAM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.4% over 20 days), RSI 55

RSI (14): 54.6 · Price: $52.30

IVZ

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 59

RSI (14): 58.8 · Price: $32.02

Fundamentals Snapshot

Metric BAM IVZ
Market Cap
Forward P/E 24.1 9.8
Trailing P/E 30.3
Revenue (TTM)
Revenue Growth 0.6% 0.2%
Gross Margin 0.7% 0.3%
Operating Margin 0.7% 0.2%
EPS 1.70 -0.66
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.